Picture of Amphastar Pharmaceuticals logo

AMPH — Amphastar Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapSuper Stock

Brief: FDA Approves First Generic Of Drug Used To Treat Severe Hypoglycemia

Dec 28 (Reuters) - FDA:
    * FDA - APPROVES FIRST GENERIC OF DRUG USED TO TREAT SEVERE
HYPOGLYCEMIA
    * FDA - FDA GRANTED APPROVAL OF THIS GENERIC GLUCAGON FOR
INJECTION TO AMPHASTAR PHARMACEUTICALS, INC. OF RANCHO
CUCAMONGA, CALIF

Source text: [https://bit.ly/3aPuil9]

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Amphastar Pharmaceuticals

See all news